Non-compliance and inertia in hypertensive Spaniards at high cardiovascular risk: CUMPLE study

Current Medical Research and Opinion

Volumn 30, Issue 1, 2014, Pages 11-17

  Márquez Contreras, Emilio ^a   Gil Guillén, Vicente F ^b,c   De La Figuera Von Wichmann, Mariano ^d   Franch Nadal, Josep ^e   Llisterri Caro, Jose Luis ^f   Martell Claros, Nieves ^g   Martin De Pablos, José Luis ^a   Casado Martinez, José Joaquin ^a   Bertomeu Gonzalez, Vicente ^b   Pertusa Martínez, Salvador ^b   Carratalá Munuera, Concepción ^b   Orozco Beltrán, Domingo ^b   Lopez Pineda, Adriana ^b  

^a La Orden Clinical Management Unit   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c Research Unit at the Elda Department of Health   (Spain)

^d EAP Sardenya   (Spain)

^e EAP Raval Sud y Unitat Suport A la Recerca IDIAP   (Spain)

^f Benlloch Health Centre   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Antihypertensive; Compliance; Medical adherence; Primary healthcare; Therapeutic inertia

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL PRACTICE; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; TREATMENT FAILURE; TREATMENT REFUSAL;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 84890487591     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2013.849237     Document Type: Article

References (34)

1. Má rquez-Contreras E, Martell-Claros N, Gil-Guillé n V, et al; Compliance Group of the Spanish Society of Hypertension (SEE). Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: The EAPACUM-HTA study. J Hypertens 2006;24:169-75
2. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30
3. Hughes D. When drugs don't work: Economic assessment of enhancing compliance with interventions supported by electronic monitoring devices. Pharmacoeconomics 2007;25:621-35
4. Má rquez Contreras E, Gil Guillé n V, Martell Claros N, et al. Aná lisis de los estudios publicados sobre el incumplimiento terapé utico en el tratamiento de la HTA en España, entre los años 1984 y 2005. Aten Primaria 2006;38:325-32
5. Llisterri Caro JL, Rodríguez Roca GC, Alonso Moreno FJ, et al. Evolució n del control de la presió n arterial en España en el período 2002-2006. Estudios PRESCAP. Hipertensió n 2009;26:257-65
6. Má rquez Contreras E, Vegazo García O, Martell Claros N, et al. Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension. ETECUM-HTA study. Blood Press 2005;14:151-8
7. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001;135:825-34
8. Chobanian AV, Bakris GL, Black HR, et al Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52
9. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007;167:141-7. Erratum in: Arch Intern Med 2007;167:648
10. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. Blood Press 2009;18:308-47
11. [VALUE study underscores the importance of reaching goal blood pressure values for minimization of cardiovascular risks]. Praxis (Bern 1994). 2004 Oct 27;93:1836
12. Julius S, Weber MA, Kjeldsen SE, et al. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: Outcomes in patients receiving monotherapy. Hypertension 2006;48:385-91
13. Mancia G, De Backer G, Dominiczak A, et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87. Erratum in: J Hypertens 2007;25:1749
14. Cushman WC, Ford CE, Cutler JA, et al ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393-404
15. Gil Guillé n VF, Orozco Beltrá n D, Quirce André s F, et al. Aplicació n prá ctica de la estadística. In: Tratado de epidemiología clínica. 2nd Department of Medicine and Psychiatry. University of Alicante. Madrid: Cyma Duphont-Pharma, 1995:101-58
16. Armario P, Waeber B. Therapeutic strategies to improve control of hypertension. J Hypertens 2013;31(Suppl 1):S9-12
17. Má rquez Contreras E, Martell Claros N, Gil Guillé n V, et al. Intervenció n no farmacoló gica como estrategia para favorecer el control de la HTA y mejorar el cumplimiento antihipertensivo. Aten Primaria 2009;41:501-10
18. Van Onzenoort HA, Verberk WJ, Kroon AA, et al. Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-To-moderate hypertension. J Hypertens 2010;28:622-7
19. Gil VF, Puras A, Suá rez E, et al. Influencia del incumplimiento terapé utico en los pacientes con hipertensió n esencial no controlados con monoterapia. Med Clin 2001;116:109-13
20. Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006;47:345-51
21. Phillips LS, Twombly JG. It's time to overcome clinical inertia. Ann Intern Med 2008;148:783-5
22. Redó n J, Coca A, Lá zaro P, et al. Factors associated with therapeutic inertia in hypertension: Validation of a predictive model. J Hypertens 2010;28:1770-7
23. Gil-Guillé n V, Orozco-Beltrán D, Pé rez RP, et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: Quantification and associated factors. Blood Press 2010;19:3-10
24. Perreault S, Yu AY, Cô té R, et al. Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes. Neurology 2012;79:2037-43
25. Ferrari P, Hess L, Pechere-Bertschi A, et al. Reasons for not intensifying antihypertensive treatment (RIAT): A primary care antihypertensive intervention study. J Hypertens 2004;22:1221-9
26. Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002;162:413-20
27. Sanfelix-Genové s J, Gil-Guillé n VF, Orozco-Beltran D, et al. Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and/or vitamin D supplements: A cross-sectional, observational study of postmenopausal women. Drugs Aging 2009;26:861-9
28. Gil-Guillé n V, Orozco-Beltrá n D, Carratalá -Munuera C, et al. Clinical inertia in poorly controlled elderly hypertensive patients: A cross-sectional study in Spanish physicians to ascertain reasons for not intensifying treatment. Am J Cardiovasc Drugs 2013;13:213-19
29. O'Connor PJ, Sperl-Hillen JAM, Johnson PE, et al. Clinical inertia and outpatient medical errors. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb
30. Má rquez-Contreras E, de la Figuera-Von Wichmann M, Franch-Nadal J, et al. Do patients with high vascular risk take antihypertensive medication correctly? Cumple-MEMS Study. Rev Esp Cardiol (Engl Ed) 2012;65:544-50
31. Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-64
32. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008 Apr 16;(2):CD000011
33. Merino J, Gil V, Cañizares R. Mé todos de medida del cumplimiento aplicado a las enfermedades cardiovasculares. Gil VF (ed.) Cumplimiento terapé utico. Med Clin (Bar) 2001;116(Suppl 2):38-45
34. Má rquez-Contreras E, Coca A, de la Figuera von Wichmann M, et al; Control-Project Researchers. [Cardiovascular risk profile of uncontrolled hypertensive patients. The Control-Project study] [in Spanish]. Med Clin (Barc) 2007;128:86-91